Because people who have the APOE e4 gene variant appear to possess a higher threat of great problems, the FDA recommends staying tested for the gene variant before starting treatment with lecanemab or donanemab. No new basic safety indicators ended up noticed with continued lecanemab treatment. Soon after the primary https://chandran531lve0.activosblog.com/profile